<DOC>
	<DOCNO>NCT01127607</DOCNO>
	<brief_summary>It well recognize Attention-Deficit/Hyperactivity Disorder ( ADHD ) chronic disorder childhood extend adulthood many individual . A number impairment daily life function identify adult ADHD , include marital distress , risky driving , use less effective parenting practice ( e.g. , Barkley , 2006 ) . Specifically , parent ADHD find use inconsistent discipline , less parental involvement , less positive reinforcement child compare parent without ADHD ( e.g. , Chen &amp; Johnston , 2007 ; Chronis-Tuscano , Clarke , Rooney , Diaz , &amp; Pian , 2008 ) . While evidence stimulant medication improve parental functioning adult ADHD , one study specifically explore use stimulant medication parenting ( Chronis-Tuscano , Seymour , Stine , Jones , Jiles , Rooney , et al. , 2008 ) . The purpose study explore whether stimulant medication , lisdexamfetamine , improve parent functioning . Measures parent behavior , parental psychosocial functioning , child psychosocial functioning collect . It hypothesize lisdexamfetamine associate improvement assessment .</brief_summary>
	<brief_title>Does Pharmacological Treatment Attention Deficit Hyperactivity Disorder ( ADHD ) Adults Enhance Parenting Performance ?</brief_title>
	<detailed_description>Seventy family least one parent ( either mother father serve identify subject ) school-aged child ( ages 5-16 ) ADHD recruit participate randomize , placebo-controlled trial lisdexamfetamine ass acute prolonged effect medication usage parent-child interaction . The protocol employ traditional self-report measure parental competency function use study , supplement one widely use observational laboratory task . Families recruit roll basis length study approximately 8 week . In first three week study , parent complete dose optimization phase find optimal dose lisdexamfetamine . Lisdexamfetamine initiate dose 30mg increase 50mg week 2 70mg week 3 . During week 4 , measure acute effect lisdexamfetamine collect , parent complete observational laboratory parent child interaction task two time ( i.e. , lisdexamfetamine placebo- phase I ) . In remain four week study ( phase 2 ) subject comparison conduct . Half parent randomize receive lisdexamfetamine half receive placebo . Measures parent function collected end phase 2 parent complete observational laboratory task , allow exploration prolonged lisdexamfetamine treatment parent-child interaction .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Lisdexamfetamine Dimesylate</mesh_term>
	<criteria>Parents diagnosis ADHD , also child ADHD age 516 Parents follow : identified structural heart abnormality health condition significantly affect heart performance ( e.g. , hypertension ) , rest systolic blood pressure ≥140 diastolic blood pressure ≥90 , pregnant breast feeding , significant psychiatric problem ADHD currently require medication emergent psychiatric treatment , medical/psychiatric illness could worsen stimulant ( seizure disorder , Tourette 's Disorder hyperthyroidism ) , alcohol substance abuse problem past 6 month . Children follow : psychiatric problem ADHD , Oppositional Defiant Disorder ( ODD ) , Conduct Disorder ( CD ) require medication emergent psychiatric treatment , either parent child participate parentchild interaction task use study last 6 month , either part study clinical treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>parent</keyword>
</DOC>